Abstract
Zijian Feng and colleagues argue that sustained elimination of SARS-CoV-2 in China offers flexibility in covid-19 vaccination policy and discuss the anticipated challenges and systematic monitoring necessary to keep the immunisation component of the response on track
MeSH terms
-
COVID-19 / epidemiology
-
COVID-19 / immunology*
-
COVID-19 / prevention & control*
-
COVID-19 Vaccines / immunology*
-
China / epidemiology
-
Humans
-
Mass Vaccination / organization & administration*
-
Mass Vaccination / statistics & numerical data
-
Pandemics
-
Quarantine
-
Risk Assessment
-
SARS-CoV-2